BRPI0800357A2 - método para produção de uma vacina estabilizada - Google Patents

método para produção de uma vacina estabilizada

Info

Publication number
BRPI0800357A2
BRPI0800357A2 BRPI0800357-2A BRPI0800357A BRPI0800357A2 BR PI0800357 A2 BRPI0800357 A2 BR PI0800357A2 BR PI0800357 A BRPI0800357 A BR PI0800357A BR PI0800357 A2 BRPI0800357 A2 BR PI0800357A2
Authority
BR
Brazil
Prior art keywords
vaccine
stabilized
producing
hydrostatic pressure
high hydrostatic
Prior art date
Application number
BRPI0800357-2A
Other languages
English (en)
Inventor
Luciane Pinto Gaspar
Silva Freire Marcos Da
De Oliveira Andrea Cheble
Da Silva Jerson Lima
Original Assignee
Fundacao Oswaldo Cruz
Univ Fed Do Rio De Janeiro Ufrj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz, Univ Fed Do Rio De Janeiro Ufrj filed Critical Fundacao Oswaldo Cruz
Priority to BRPI0800357-2A priority Critical patent/BRPI0800357A2/pt
Priority to PCT/BR2009/000058 priority patent/WO2009111849A1/en
Publication of BRPI0800357A2 publication Critical patent/BRPI0800357A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

MéTODO PARA PRODUçãO DE UMA VACINA ESTABILIZADA A presente invenção se refere ao campo das vacinas, mais particularmente, à estabilização das três cepas vacinais da poliomielite, presentes na Vacina Oral contra a Poliomielite (VOP) . A alta pressão hidrostática é uma tecnologia que é extremamente segura, limpa e económica. Além disso, uma vacina comercial estabilizada pela ação da alta pressão hidrostática evita a necessidade de energia elétrica para armazenamento do material.
BRPI0800357-2A 2008-03-10 2008-03-10 método para produção de uma vacina estabilizada BRPI0800357A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0800357-2A BRPI0800357A2 (pt) 2008-03-10 2008-03-10 método para produção de uma vacina estabilizada
PCT/BR2009/000058 WO2009111849A1 (en) 2008-03-10 2009-03-10 Method for stabilized vaccine production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0800357-2A BRPI0800357A2 (pt) 2008-03-10 2008-03-10 método para produção de uma vacina estabilizada

Publications (1)

Publication Number Publication Date
BRPI0800357A2 true BRPI0800357A2 (pt) 2009-10-27

Family

ID=41064685

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0800357-2A BRPI0800357A2 (pt) 2008-03-10 2008-03-10 método para produção de uma vacina estabilizada

Country Status (2)

Country Link
BR (1) BRPI0800357A2 (pt)
WO (1) WO2009111849A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012MU00206A (pt) 2012-01-20 2013-08-09
CN104768577B (zh) 2012-08-30 2020-06-09 梅里亚有限公司 高压设备和用于制备灭活疫苗和用于重折叠/增溶重组蛋白的方法
ZA201501696B (en) 2012-08-30 2016-01-27 Merial Ltd Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2113348T3 (es) * 1989-08-15 1998-05-01 Massachusetts Inst Technology Composiciones de vacunas estabilizadas.
WO1997033612A1 (en) * 1996-03-15 1997-09-18 Immunotherapy, Inc. Dialdehydes as immunostimulatory adjuvants and cross-linkers for producing immunogenic preparations and generating pressure and cross-link treated cells for enhancing and augmenting the immune response against cancers, tumors and pathogenic diseases
US6270723B1 (en) * 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
CN1099295C (zh) * 1998-09-04 2003-01-22 中国科学院上海生物化学研究所 鸡传染性法氏囊病病毒疫苗、制备方法及其应用
US20060088909A1 (en) * 2002-05-17 2006-04-27 Compans Richard W Virus-like particles, methods of preparation, and immunogenic compositions

Also Published As

Publication number Publication date
WO2009111849A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
PY1043137A (es) Rebaudioside d de alta pureza y sus aplicaciones
BR112013025424A2 (pt) processos para produzir uma composição imunogênica, e para fabricar uma vacina, e, composição imunogênica
PL387319A1 (pl) Nowy szczep bakterii Salmonella enterica s. Typhimurium, jego zastosowanie i sposób otrzymywania terapeutycznego wektora szczepionkowego
BR112015001653A2 (pt) método e aparelho para a preparação de álcool isopropílico
CO6460761A2 (es) Vacuna viva modificada de mycoplasma bovis mejorada, métodos de producción de vacunas vivas de mycoplasma bovis, vacunas de combinación y métodos de tratamiento
BR112013002969B8 (pt) processo para remineralização da água, e, uso de um carbonato de cálcio micronizado
BR112012006417A2 (pt) bactérias gram-negativas modificadas para uso como vacinas.
AR085943A1 (es) Composicion antimicrobiana
BRPI0813307C1 (pt) composição imunogênica, vacina, e, processo para fabricar a vacina
CL2012000869A1 (es) Composicion que comprende cepa seleccionada de lactobacillus plantarum cect 7527, o cepas mutantes de la misma; uso de una composicion para prevenir y/o tratar transtornos cardiovasculares.
MX2014013755A (es) Indicador de calor de funcion dual y metodo de fabricacion.
MY173503A (en) Nasal influenza vaccine composition
CL2016003207A1 (es) Proceso para la producción de amoníaco y derivados, en particular urea
MX351174B (es) Microorganismos que producen acido eicosapentaenoico, composiciones de acidos grasos,y metodos para prepararlos y usos de los mismos.
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
PH12013502442A1 (en) Inactivated dengue virus vaccine
MX351627B (es) Bioproteccion usando cepas de lactobacillus paracasei.
BR112014015656A2 (pt) aplicador de vapor para um vaporizador de roupa, vaporizador de roupa, e acessório para um aplicador de vapor de um vaporizador de roupa
FI20115274A7 (fi) Menetelmä mikro- ja nanokiteisen selluloosan valmistamiseksi
EP2464435A4 (en) Configurations and methods of generating low-pressure steam
AR088634A1 (es) Uso de composiciones que comprenden 1,1,1,2,3-pentafluoropropano y opcionalmente z-1,1,1,4,4,4-hexafluoro-2-buteno en ciclos de energia
BR112012030659B8 (pt) Parvovírus vivo atenuado, vacinas que o compreendem e método para a fabricação das referidas vacinas
BRPI0800357A2 (pt) método para produção de uma vacina estabilizada
AR101148A1 (es) Proceso para la producción de una solución inyectable estable con bajo contenido de noradrenalina
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: FUNDACAO OSWALDO CRUZ - FIOCRUZ (BR/RJ) , UNIVERSI

Free format text: TRANSFERIDO PARTE DOS DIREITOS DE: FUNDACAO OSWALDO CRUZ - FIOCRUZ

B03A Publication of an application: publication of a patent application or of a certificate of addition of invention
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal